Oligometastases and Oligo-recurrence: the New Era of Cancer Therapy

Overview

Journal Jpn J Clin Oncol

Publisher Oxford University Press

Specialty Oncology

Date 2010 Jan 6

PMID 20047860

Citations 184

Authors

Yuzuru Niibe

Kazushige Hayakawa

Affiliations

Soon will be listed here.

Abstract

Recurrence or metastasis of cancer has been considered to occur in the last stage of the patient's life. However, the new notions of oligometastases and oligo-recurrence have been proposed and the paradigm shift in the conceptualization of cancer metastasis or cancer recurrence. Oligometastases is the state in which the patient shows distant relapse in only a limited number of regions. Local therapy such as surgery, radiotherapy and radiofrequency ablation for the relapsed sites could thus improve patient's survival. On the other hand, oligo-recurrence is a notion similar to oligometastases. However, the conditions of oligo-recurrence has a primary site of the cancer controlled, meaning that all gross recurrent or metastatic sites could be treated using local therapy.

Citing Articles

Efficacy Analysis of Hypofractionated Radiotherapy for Oligometastatic Tumors: A Retrospective Study.

Sun Q, Zhao H, Zhang X, Zhang S, He Z, Wang G Technol Cancer Res Treat. 2025; 24():15330338241310155.

PMID: 39819190 PMC: 11742154. DOI: 10.1177/15330338241310155.

Oligo-Recurrence in Lung Cancer; The Most Curable State Among Advanced Disease?.

Shimada Y Cancers (Basel). 2024; 16(23).

PMID: 39682272 PMC: 11639969. DOI: 10.3390/cancers16234086.

Intratumoral Treatment in Lung Cancer: Is It Time to Move Towards Clinical Practice?.

Pagliari G, Colonese F, Canova S, Abbate M, Sala L, Petrella F Cancers (Basel). 2024; 16(23).

PMID: 39682081 PMC: 11639858. DOI: 10.3390/cancers16233892.

Challenges in the Understanding of Oligometastatic Disease in Clinical Practice.

Navarro-Domenech I, Barry A, Tsai J, Ma G, Wong P Cureus. 2024; 16(10):e72500.

PMID: 39600746 PMC: 11594868. DOI: 10.7759/cureus.72500.

Prognostic factors after radical local therapy for oligo-recurrence of non-small cell lung cancer.

Sonoda D, Kondo Y, Maruyama R, Naito M, Mikubo M, Shiomi K Gen Thorac Cardiovasc Surg. 2024; .

PMID: 39313740 DOI: 10.1007/s11748-024-02084-0.

References

Pastorino U, Buyse M, Friedel G, Ginsberg R, Girard P, Goldstraw P . Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. J Thorac Cardiovasc Surg. 1997; 113(1):37-49. DOI: 10.1016/s0022-5223(97)70397-0. View

Andrews D, Scott C, Sperduto P, Flanders A, Gaspar L, Schell M . Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet. 2004; 363(9422):1665-72. DOI: 10.1016/S0140-6736(04)16250-8. View

Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T . Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys. 1997; 37(4):745-51. DOI: 10.1016/s0360-3016(96)00619-0. View

Hellman S, Weichselbaum R . Oligometastases. J Clin Oncol. 1995; 13(1):8-10. DOI: 10.1200/JCO.1995.13.1.8. View

Kim J, Kim J, Kim S, Kim K, Cho M . Hyperfractionated radiotherapy with concurrent chemotherapy for para-aortic lymph node recurrence in carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 2003; 55(5):1247-53. DOI: 10.1016/s0360-3016(02)04401-2. View

Uematsu M, Shioda A, Tahara K, Fukui T, Yamamoto F, Tsumatori G . Focal, high dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients: a preliminary experience. Cancer. 1998; 82(6):1062-70. DOI: 10.1002/(sici)1097-0142(19980315)82:6<1062::aid-cncr8>3.0.co;2-g. View

Niibe Y, Kenjo M, Kazumoto T, Michimoto K, Takayama M, Yamauchi C . Multi-institutional study of radiation therapy for isolated para-aortic lymph node recurrence in uterine cervical carcinoma: 84 subjects of a population of more than 5,000. Int J Radiat Oncol Biol Phys. 2006; 66(5):1366-9. DOI: 10.1016/j.ijrobp.2006.07.1384. View

Niibe Y, Kazumoto T, Toita T, Yamazaki H, Higuchi K, Ii N . Frequency and characteristics of isolated para-aortic lymph node recurrence in patients with uterine cervical carcinoma in Japan: a multi-institutional study. Gynecol Oncol. 2006; 103(2):435-8. DOI: 10.1016/j.ygyno.2006.03.034. View

Niibe Y, Nakano T, Ohno T, Suzuki Y, Oka K, Tsujii H . Prognostic significance of c-erbB-2/HER2 expression in advanced uterine cervical carcinoma with para-aortic lymph node metastasis treated with radiation therapy. Int J Gynecol Cancer. 2003; 13(6):849-55. DOI: 10.1111/j.1525-1438.2003.13397.x. View

10.

Choi C, Cho C, Yoo S, Kim M, Yang K, Yoo H . Image-guided stereotactic body radiation therapy in patients with isolated para-aortic lymph node metastases from uterine cervical and corpus cancer. Int J Radiat Oncol Biol Phys. 2008; 74(1):147-53. DOI: 10.1016/j.ijrobp.2008.07.020. View

11.

Blomgren H, Lax I, Naslund I, Svanstrom R . Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. Acta Oncol. 1995; 34(6):861-70. DOI: 10.3109/02841869509127197. View

12.

Niibe Y, Karasawa K, Nakamura O, Shinoura N, Okamoto K, Yamada R . Survival benefit of stereotactic radiosurgery for metastatic brain tumors in patients with controlled primary lesions and no other distant metastases. Anticancer Res. 2003; 23(5b):4157-9. View

13.

Nagata Y, Negoro Y, Aoki T, Mizowaki T, Takayama K, Kokubo M . Clinical outcomes of 3D conformal hypofractionated single high-dose radiotherapy for one or two lung tumors using a stereotactic body frame. Int J Radiat Oncol Biol Phys. 2002; 52(4):1041-6. DOI: 10.1016/s0360-3016(01)02731-6. View

14.

Rusthoven K, Kavanagh B, Cardenes H, Stieber V, Burri S, Feigenberg S . Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol. 2009; 27(10):1572-8. DOI: 10.1200/JCO.2008.19.6329. View

15.

Herfarth K, Debus J, Lohr F, Bahner M, Rhein B, Fritz P . Stereotactic single-dose radiation therapy of liver tumors: results of a phase I/II trial. J Clin Oncol. 2001; 19(1):164-70. DOI: 10.1200/JCO.2001.19.1.164. View

16.

Milano M, Zhang H, Metcalfe S, Muhs A, Okunieff P . Oligometastatic breast cancer treated with curative-intent stereotactic body radiation therapy. Breast Cancer Res Treat. 2008; 115(3):601-8. DOI: 10.1007/s10549-008-0157-4. View

17.

Norihisa Y, Nagata Y, Takayama K, Matsuo Y, Sakamoto T, Sakamoto M . Stereotactic body radiotherapy for oligometastatic lung tumors. Int J Radiat Oncol Biol Phys. 2008; 72(2):398-403. DOI: 10.1016/j.ijrobp.2008.01.002. View

18.

Kocher M, Maarouf M, Bendel M, Voges J, Muller R, Sturm V . Linac radiosurgery versus whole brain radiotherapy for brain metastases. A survival comparison based on the RTOG recursive partitioning analysis. Strahlenther Onkol. 2004; 180(5):263-7. DOI: 10.1007/s00066-004-1180-y. View

19.

Punglia R, Morrow M, Winer E, Harris J . Local therapy and survival in breast cancer. N Engl J Med. 2007; 356(23):2399-405. DOI: 10.1056/NEJMra065241. View

20.

Mendez Romero A, Wunderink W, Hussain S, de Pooter J, Heijmen B, Nowak P . Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase i-ii study. Acta Oncol. 2006; 45(7):831-7. DOI: 10.1080/02841860600897934. View